FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37858011000001105: Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1775141000001115 Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1775151000001117 Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Is a Agomelatine 25mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Has AMP Agomelatine 25mg tablets (Neuraxpharm UK Ltd) true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Agomelatine true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Agomelatine 25mg tablets (Neuraxpharm UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start